Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts
Journal of the American Medical Informatics Association · 2024
DOI: 10.1093/jamia/ocae094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, 2024. Verfasst von Yukinobu Kawakami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan. Hauptthemen laut MEDLINE: Drug Interactions, Knowledge Bases, RxNorm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Linking information on Japanese pharmaceutical products to global knowledge bases (KBs) would enhance international collaborative research and yield valuable insights. However, public access to mappings of Japanese pharmaceutical products that use international controlled vocabularies remains limited. This study mapped YJ codes to RxNorm ingredient classes, providing new insights by comparing Japanese and international drug-drug interaction (DDI) information using a case study methodology. Materials and Methods Tables linking YJ codes to RxNorm concepts were created using the application programming interfaces of the Kyoto Encyclopedia of Genes and Genomes and the National Library of Medicine. A comparative analysis of Japanese and international DDI information was thus performed by linking to an international DDI KB.
Results
There was limited agreement between the Japanese and international DDI severity classifications. Cross-tabulation of Japanese and international DDIs by severity showed that 213 combinations classified as serious DDIs by an international KB were missing from the Japanese DDI information.
Discussion
It is desirable that efforts be undertaken to standardize international criteria for DDIs to ensure consistency in the classification of their severity.
Conclusion
The classification of DDI severity remains highly variable. It is imperative to augment the repository of critical DDI information, which would revalidate the utility of fostering collaborations with global KBs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Informatics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
- Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Zitieren
APA
Kawakami, Y., Matsuda, T., Hidaka, N., Tanaka, M., & Kimura, E. (2024). Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocae094
Vancouver
Kawakami Y, Matsuda T, Hidaka N, Tanaka M, Kimura E. Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts. Journal of the American Medical Informatics Association. 2024. doi:10.1093/jamia/ocae094
BibTeX
@article{Kawakami2024,
author = {Kawakami, Yukinobu and Matsuda, Takuya and Hidaka, Noriaki and Tanaka, Mamoru and Kimura, Eizen},
title = {Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts},
journal = {Journal of the American Medical Informatics Association},
year = {2024},
doi = {10.1093/jamia/ocae094}
}
EUVIMED